ArticleActa pharmacologica Sinica2025

A recombinant fragment antigen-binding (Fab) of trastuzumab displays low cytotoxic profile in adult human cardiomyocytes: first evidence and the key implication of FcγRIIA receptor.

Anna De Bartolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.